U.S. flag

An official website of the United States government

NM_002693.3(POLG):c.1790G>A (p.Arg597Gln) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 21, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003230576.1

Allele description [Variation Report for NM_002693.3(POLG):c.1790G>A (p.Arg597Gln)]

NM_002693.3(POLG):c.1790G>A (p.Arg597Gln)

Gene:
POLG:DNA polymerase gamma, catalytic subunit [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q26.1
Genomic location:
Preferred name:
NM_002693.3(POLG):c.1790G>A (p.Arg597Gln)
Other names:
p.Arg597Gln
HGVS:
  • NC_000015.10:g.89325609C>T
  • NG_008218.2:g.14187G>A
  • NM_001126131.2:c.1790G>A
  • NM_002693.3:c.1790G>AMANE SELECT
  • NP_001119603.1:p.Arg597Gln
  • NP_002684.1:p.Arg597Gln
  • NP_002684.1:p.Arg597Gln
  • LRG_765t1:c.1790G>A
  • LRG_765:g.14187G>A
  • LRG_765p1:p.Arg597Gln
  • NC_000015.9:g.89868840C>T
  • NM_002693.2:c.1790G>A
Protein change:
R597Q
Links:
dbSNP: rs1001570418
NCBI 1000 Genomes Browser:
rs1001570418
Molecular consequence:
  • NM_001126131.2:c.1790G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002693.3:c.1790G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003929294Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Apr 21, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and Molecular Features of POLG-Related Sensory Ataxic Neuropathy with Dysarthria and Ophthalmoparesis.

Li LX, Jiang LT, Pan YG, Zhang XL, Pan LZ, Nie ZY, Chen YH, Jin LJ.

J Mol Neurosci. 2021 Dec;71(12):2462-2467. doi: 10.1007/s12031-021-01831-9. Epub 2021 Apr 1.

PubMed [citation]
PMID:
33791913

Novel and recurrent nuclear gene variations in a cohort of Chinese progressive external ophthalmoplegia patients with multiple mtDNA deletions.

Hou Y, Zhao X, Xie Z, Yu M, Lv H, Zhang W, Yuan Y, Wang Z.

Mol Genet Genomic Med. 2022 May;10(5):e1921. doi: 10.1002/mgg3.1921. Epub 2022 Mar 15.

PubMed [citation]
PMID:
35289132
PMCID:
PMC9034679

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003929294.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

Variant summary: POLG c.1790G>A (p.Arg597Gln) results in a conservative amino acid change to a highly conserved residue (HGMD) in the encoded protein sequence. Another missense variant altering this residue (p.Arg597Trp) is classified as pathogenic/likely pathgenic in ClinVar. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 250900 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1790G>A has been reported in the literature in an individual affected with progressive external ophthalmoplegia who was reported as compound heterozygous with a likely pathogenic variant (Hou_2022). These data suggest the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three submitters have provided clinical-significance assessments for this variant to ClinVar after 2014, and classified it as pathogenic (n=1) or uncertain significance (n=2). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024